Titusville, NJ, United States of America

Navdeep Jaikaria

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Sgn Nanopharma Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Navdeep Jaikaria. Retrieved from https://idiyas.com/inventor/navdeep-jaikaria

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Navdeep Jaikaria in Cannabinoid Nanoemulsions

Introduction

Navdeep Jaikaria is an innovative inventor based in Titusville, NJ (US). He has made significant contributions to the field of nanoemulsions, particularly those comprising cannabinoids. His work focuses on improving the stability and efficacy of cannabinoid formulations for medical applications.

Latest Patents

Jaikaria holds a patent for "Stable cannabinoid-comprising nanoemulsions and methods of using the same." This patent relates to the development of cannabinoid (e.g., THC, CBD, CBDi or combinations of THC and CBD) nanoemulsions that may optionally include cyclosporine. The disclosed formulations are designed to treat ophthalmic conditions such as dry eye. They demonstrate significantly improved pharmaceutical stability compared to conventional formulations.

Career Highlights

Navdeep Jaikaria is associated with Sgn Nanopharma Inc., where he continues to advance his research in cannabinoid applications. His work is pivotal in the development of innovative solutions for medical challenges.

Collaborations

Jaikaria collaborates with Pranav M Patel, contributing to the advancement of their shared research goals.

Conclusion

Navdeep Jaikaria's contributions to cannabinoid nanoemulsions represent a significant advancement in pharmaceutical technology. His innovative approach has the potential to improve treatment options for various ophthalmic conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…